The Food and Drug Administration (FDA) has approved a domestically-developed and produced antibody reagent for the COVID-19 coronavirus disease, the first of its kind licensed in Taiwan, an FDA official said Friday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan headline news
11/14/2025 09:45 AM - Business
Taiwan shares open lower
11/14/2025 09:20 AM - Society
Kaohsiung man could face stiffer child abuse penalty under revised law
11/13/2025 10:04 PM - Politics
Cabinet approves bill setting harsher penalties for fraud
11/13/2025 09:52 PM - Society
Education ministry rejects petition to delay school start times
11/13/2025 09:43 PM